492 episodes

Podcast by Managed Care Cast

Managed Care Cast Managed Care Cast

    • Science
    • 4.9 • 16 Ratings

Podcast by Managed Care Cast

    Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 1

    Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 1

    Today we’re highlighting a discussion with a panel of experts in interstitial lung disease moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.

    The topics of conversation for today’s podcast include treatment goals in patients with ILD and a review of treatment paradigms and standard of care therapies.

    • 18 min
    Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

    Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

    On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.

    • 23 min
    Generic Drug Savings Possibilities: $3.6 Billion to Medicare Using DTC Pricing

    Generic Drug Savings Possibilities: $3.6 Billion to Medicare Using DTC Pricing

    In January of this year, entrepreneur and Dallas Mavericks owner Mark Cuban launched a direct-to-consumer pharmacy called the Cost Plus Drug Company, promising savings by eliminating middlemen and charging cost plus 15% and a pharmacy fee. What if Medicare could do the same? On this episode of Managed Care Cast, we speak with a researcher who coauthored a study out this week that looked at the savings to Medicare Part D if the same model had been employed for some of the most used generic drugs.

    Hussain S. Lalani, MD, MPH, an internist and one of the coauthors, discussed the findings of the paper, published Monday in the Annals of Internal Medicine. The analysis compared the price paid by Medicare Part D plans in 2020 with the price of 89 generic drugs sold by the pharmacy in 2022.

    The researchers, from Brigham and Women’s Hospital and Harvard Medical School, used the price paid by Medicare Part D plans in 2020 and looked at the price of 89 generic drugs sold by the pharmacy in 2022.

    After adjusting for changes in drug costs between 2020 and 2022, the researchers found that Medicare paid more on 77 of the 89 generic drugs: $8.1 billion compared with $4.5 billion. Medicare would have saved as much as $3.6 billion over 1 year.

    • 19 min
    Biosimilar Whisky? This Expert Says It’s Doable, No Aging Required

    Biosimilar Whisky? This Expert Says It’s Doable, No Aging Required

    On the After Hours section of Medical World News, we like to show you what scientists, researchers, health care providers, and others are doing in their spare time to relax and recharge. On this episode of Managed Care Cast, we’re highlighting a hobby from a biosimilar expert who says he can make whisky more accessible and affordable through—you guessed it—his own biosimilar whisky.

    Sarfaraz K. Niazi, PhD, is an adjunct professor of biopharmaceutical sciences at the University of Illinois and the University of Houston, and a member of the advisory board of The Center for Biosimilars®', a sister site to AJMC.com, the website of The American Journal of Managed Care.

    On a recent episode of After Hours, he spoke with Matthew Gavidia, an assistant editor at AJMC.com, about his unusual whiskey-making hobby, the history of the traditional process, and how he distills his own biosimilar version.

    • 18 min
    Excess COVID-19 Deaths in Republican Counties Paints Voting as a Proxy for Public Health Support

    Excess COVID-19 Deaths in Republican Counties Paints Voting as a Proxy for Public Health Support

    The pandemic highlighted deep partisan divisions in the United States over public health measures. Disputes over masking and beliefs about science and vaccines that prevent severe illness and death from infection with SARS-CoV2, the virus that causes COVID-19, affected nearly every area of life. That rancor impacted death rates in counties that voted Republican in the 2020 presidential election, according to a new study out Monday in the journal Health Affairs.



    In counties where 70% or more of eligible voters chose the Republican party, there were nearly 73 additional deaths from COVID-19 per 100,000 people compared with Democratic counties (where less than 30% voted Republican).



    On today’s episode of Managed Care Cast, we speak with the lead author of the study, Neil J. Sehgal, PhD, MPH, assistant professor of health policy and management in the University of Maryland (UMD) School of Public Health. He discusses the findings of the paper, coauthored with other scholars from UMD, as well as the University of California, Irvine Program in Public Health.



    The analysis, which included the majority of US counties, controlled for other characteristics likely to influence COVID-19 transmission and death such as age, race/ethnicity, vaccine uptake, unemployment status, burden of chronic disease, and health care access.

    • 32 min
    Assessing the Association Between Income Inequality and Health

    Assessing the Association Between Income Inequality and Health

    Income inequality is a hot topic in politics today, and while the rising role of social determinants of health is being recognized in care delivery and research, a new study published in Social Science & Medicine aimed to determine to what extent income gaps are associated with Americans’ declining health.

    On this episode of Managed Care Cast, we speak with Hui Zheng, PhD, an associate professor in the Department of Sociology at Ohio State University and co-author of “Rising Childhood Income Inequality and Declining Americans’ Health.”

    The American Journal of Managed Care® sat down with Zheng to learn more about how income inequality has shifted throughout the 20th and 21st centuries and the potential implications of this shift, along with some solutions to the problem.

    • 19 min

Customer Reviews

4.9 out of 5
16 Ratings

16 Ratings

Top Podcasts In Science

Hidden Brain
Alie Ward
Jordan Harbinger
Vox
Sam Harris
PRX and Greater Good Science Center

You Might Also Like

Tradeoffs
Kaiser Health News
NPR
NPR
NPR
Freakonomics Radio + Stitcher